Yttrium-90 anti-CD45 monoclonal antibody BC8
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Yttrium-90 anti-CD45 monoclonal antibody BC8, covering 2019-01-25 to 2019-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS [Phase 1]